Cargando…
The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis
BACKGROUND: Circulating cell-free DNA (cfDNA) isolated from plasma or serum by noninvasive procedures can serve as a “liquid biopsy” and has potential as a biomarker for the tumor burden and survival prediction of breast cancer (BC). However, its prognostic value in patients with BC is currently und...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895387/ https://www.ncbi.nlm.nih.gov/pubmed/29595655 http://dx.doi.org/10.1097/MD.0000000000010197 |